Especially, the absence of biomarkers related with CKD‐MBD (ie, calcium, phosphate, PTH, and 25‐OH‐vitamin D) that may influence bone health and thus fracture risk is a weakness. This evidence concerns the gene PTH and chronic kidney disease.